Genelux Corporation (GNLX) vs Nutriband Inc. (NTRB)

Genelux Corporation and Nutriband Inc. are both Biotechnology companies. Genelux Corporation and Nutriband Inc. are of similar size ($115.2M and $110.0M). Genelux Corporation has the higher net margin (0.00% vs −430.4%) and the higher return on invested capital (0.00% vs −227.9%). Across the 16 metrics below, Genelux Corporation leads on 10 and Nutriband Inc. on 6.

Valuation

Metric GNLX NTRB Biotechnology median
P/E n/m n/m 7.88
P/S 9.91 60.12 11.47
P/B 6.92 18.26 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 8.37 58.11 10.73
Earnings yield (34.68%) (7.16%) (28.84%)
Free cash flow yield (25.73%) (3.74%) (23.03%)

Profitability

Metric GNLX NTRB Biotechnology median
Gross margin (3.42%) 33.14% 65.16%
Operating margin 0.00% (435.57%) 0.00%
Net margin 0.00% (430.43%) 0.00%
Free cash flow margin 0.00% (224.54%) 0.00%
Return on equity (177.93%) (100.79%) (57.72%)
Return on assets (121.80%) (84.56%) (49.22%)
Return on invested capital 0.00% (227.92%) 0.00%

Growth

Metric GNLX NTRB Biotechnology median
Revenue growth (TTM) — (37.25%) 5.64%
EPS growth (last fiscal year) 9.47% (160.61%) —
Revenue growth, 5-year CAGR — 16.63% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GNLX NTRB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.39 4.21 4.73
Net debt to EBITDA 0.44 0.56 0.96

Dividend

Metric GNLX NTRB Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric GNLX NTRB Biotechnology median
Market cap 109.95m 115.24m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack